UK markets open in 2 hours 54 minutes
NIKKEI 225
38,155.66 -73.45 (-0.19%) HANG SENG
19,040.83 +77.15 (+0.41%) CRUDE OIL
78.04 -0.22 (-0.28%) GOLD FUTURES
2,363.80 -11.20 (-0.47%) DOW
39,512.84 +837.14 (+2.16%) Bitcoin GBP
48,771.30 +150.39 (+0.31%)
Reneo Pharmaceuticals, Inc. (RPHM)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 60.49M |
| Enterprise value | -21.44M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 0.74 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | 0.16 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.23 |
| 52-week change 3 | -77.93% |
| S&P500 52-week change 3 | 26.27% |
| 52-week high 3 | 9.4500 |
| 52-week low 3 | 0.9800 |
| 50-day moving average 3 | 1.6871 |
| 200-day moving average 3 | 4.2917 |
Share statistics
| Avg vol (3-month) 3 | 149.58k |
| Avg vol (10-day) 3 | 112.47k |
| Shares outstanding 5 | 33.42M |
| Implied shares outstanding 6 | 33.42M |
| Float 8 | 12.57M |
| % held by insiders 1 | 3.08% |
| % held by institutions 1 | 90.70% |
| Shares short (30 Apr 2024) 4 | 3.07M |
| Short ratio (30 Apr 2024) 4 | 28.2 |
| Short % of float (30 Apr 2024) 4 | 15.88% |
| Short % of shares outstanding (30 Apr 2024) 4 | 9.19% |
| Shares short (prior month 28 Mar 2024) 4 | 2.92M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -51.66% |
| Return on equity (ttm) | -84.01% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -75.7M |
| Net income avi to common (ttm) | -70.71M |
| Diluted EPS (ttm) | -2.1700 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 82.83M |
| Total cash per share (mrq) | 2.48 |
| Total debt (mrq) | 907k |
| Total debt/equity (mrq) | 1.12% |
| Current ratio (mrq) | 29.83 |
| Book value per share (mrq) | 2.43 |
Cash flow statement
| Operating cash flow (ttm) | -75.65M |
| Levered free cash flow (ttm) | -47.77M |
© 2024 Yahoo. All rights reserved.